ViewPoint develops a nonsurgical route to cataract treatment.
AMGEN and MBC BioLabs invite you to apply for the 2019 AMGEN Golden Ticket!
Alector raised $185 million in IPO
Alector moved into MBC BioLabs on the day we opened our doors, and now just over five years later they have two programs in the clinic, a partnership with AbbVie, and are now are preparing to g [...]
Cypre and Molecular Devices sign co-marketing agreement to collaborate on delivering solutions for screening biologically relevant assays
Kolin Hribar, PhD, CEO and Founder of Cypre Inc. with their Symphony®/VersaGel® Cypre and Molecular Devices signed a co-marketing agreement to jointly market Cypre’s Symphony®/VersaGel® 3D cel [...]
Nitrome Biosciences and SyntheX are the recipients of the MBC 2018 Golden Ticket program sponsored by Celgene Corporation.
Alector's Arnon Rosenthal (left) and Sabah Oney. TODD JOHNSON | SAN FRANCISCO BUSINESS TIMES By Ron Leuty – Reporter, San Francisco Business Times Jan 7, 2019, 5:18pm EST Read original online a [...]